Skip to main content
OpenTrials

Clinical trial condition

Breast Cancer

Explore clinical trials studying Breast Cancer. Study availability and eligibility vary by location and protocol.

6,460 public trials 1,142 recruiting studies
Refine in advanced search Browse all conditions

Breast Cancer trial results

Active, Not Recruiting

PErsonalized TREatment of High-risk MAmmary Cancer - the PETREMAC Trial

NCT02624973

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • Akershus University Hospital Lørenskog, Akershus, Norway
  • Haukeland University Hospital Bergen, Hordaland, Norway
  • Helse Fonna Haugesund, Rogaland, Norway
  • Helse Stavanger Stavanger, Rogaland, Norway
View Trial Details
Active, Not Recruiting

Classifying for HER2 Dependence to De-Escalate Neoadjuvant Chemotherapy in Patients With HER2+ Early Breast Cancer Undergoing HER2 Double-Blockade

NCT06068985

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
Locations
  • Núcleo de Oncologia da Bahia - NOB (Oncoclínicas) Salvador, Estado de Bahia, Brazil
  • Centro de Câncer de Brasília - CETTRO (Oncoclínicas) Brasília, Federal District, Brazil
  • Oncocentro Belo Horizonte (Oncoclínicas) Belo Horizonte, Minas Gerais, Brazil
  • Centro de Pesquisa Vencer & Oncoclínica Teresina, Piauí, Brazil
View all 14 locations
View Trial Details
Active, Not Recruiting

Onvansertib + Paclitaxel In TNBC

NCT05383196

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +15 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Beth Israel Deaconness Medical Center Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Active, Not Recruiting

TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer (Sub-Study A)

NCT05548127

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • Stanford Women's Cancer Center Palo Alto, California, United States
  • UCSF Medical Center at Mission Bay San Francisco, California, United States
  • Moffitt Cancer Center - International Plaza Tampa, Florida, United States
  • Moffitt Cancer Center, Richard M. Shulze Family Foundation Outpatient Center Tampa, Florida, United States
View all 39 locations
View Trial Details
Active, Not Recruiting

Vepdegestrant (ARV-471/PF-07850327) + Palbociclib vs Letrozole + Palbociclib in ER(+)/HER2(-) Advanced Breast Cancer

NCT05909397

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • BRCR Global Plantation, Florida, United States
  • BRCR Medical Center Inc Plantation, Florida, United States
  • Virginia Oncology Associates Norfolk, Virginia, United States
  • Cancer Research SA Adelaide, South Australia, Australia
View all 29 locations
View Trial Details
Active, Not Recruiting

S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer

NCT01674140

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
View all 1459 locations
View Trial Details
Active, Not Recruiting

Gedatolisib Plus Fulvestrant With or Without Palbociclib vs Standard-of-Care for the Treatment of Patients With Advanced or Metastatic HR+/HER2- Breast Cancer (VIKTORIA-1)

NCT05501886

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +8 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Arizona Oncology (US Oncology/McKesson) - Goodyear Goodyear, Arizona, United States
  • St. Bernards Medical Center Jonesboro, Arkansas, United States
  • CARTI Cancer Center Little Rock, Arkansas, United States
View all 235 locations
View Trial Details
Active, Not Recruiting

P-MUC1C-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Advanced or Metastatic Solid Tumors

NCT05239143

Conditions
Adenocarcinoma, Adnexal Diseases, Breast Cancer, +66 more
Locations
  • University of California, Irvine Medical Center Irvine, California, United States
  • Cedars Sinai Medical Center Los Angeles, California, United States
  • University of California, San Diego San Diego, California, United States
  • University of California, San Francisco San Francisco, California, United States
View all 14 locations
View Trial Details
Active, Not Recruiting

A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors

NCT04478279

Conditions
Astrocytoma, Brain Cancer, Brain Diseases, +43 more
Locations
  • University of California, San Francisco San Francisco, California, United States
  • Sarah Cannon Research Institute Denver, Colorado, United States
  • Northwestern Medicine Cancer Centers Warrenville, Illinois, United States
  • START Midwest Grand Rapids, Michigan, United States
View Trial Details

Related conditions